Ortung von Implantierbarer Leitung mittels Ecap
Anmelder: Medtronic, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP3991784
- Aktenzeichen
- EP21201439
- Anmeldetag
- 7. Oktober 2021
- Veröffentlichung
- 6. März 2024
- Erteilung
- 6. März 2024
- Rechtsraum
- EP
- IPC
- A61N1/36// A61N1/05A61N1/375A61N1/372
Abstract
Systems, devices, methods, and techniques are described for using evoked compound action potential (ECAP) signals to determine an implant location for a lead. An example method includes receiving first information representative of a first evoked compound action potential (ECAP) signal sensed in response to a first control stimulus delivered to a first location adjacent to a spinal cord of a patient. The method also includes receiving, second information representative of a second ECAP signal in response to a second control stimulus delivered to a second location adjacent to the spinal cord of the patient. Additionally, the method includes outputting a first indication of the first information representative of the first ECAP signal and a second indication of the second information representative of the second ECAP signal.
Anmelder
- Firma
- Medtronic, Inc.
- Land
- 🇺🇸 USA
US-amerikanischer Medizintechnikkonzern, entwickelt Implantate, Geräte und Therapiesysteme unter anderem für Herz-Kreislauf-, Diabetes- und neurologische Erkrankungen.
4.790 Patente in unserer Datenbank